Drug Reference
Insulin, Regular, Human
Insulins and analogues for injection, fast-acting
Fact box
- Therapeutic class
- Insulins and analogues for injection, fast-acting
- Action class
- Insulin
- Chemical class
- Insulin
- Habit forming
- No
Brand names
AfrezzaHumulinHumulin RMyxredlinNovolinNovolin R
Available as
4 UNT · Powder8 UNT · Powder12 UNT · Powder3 ML100 ML · Injection85 UNT/ML50 UNT/ML90 UNT/ML80 UNT/ML60 UNT/ML500 UNT/ML · Injectable Solution100 UNT/ML · Injectable Solution70 UNT/ML75 UNT/ML
No structured FDA label was available. Use the authoritative links below.
Current FDA labels (DailyMed)
- NOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [NOVO NORDISK PHARMACEUTICAL INDUSTRIES, LP]
- NOVOLIN N (HUMAN INSULIN) INJECTION, SUSPENSION [NOVO NORDISK PHARMACEUTICAL INDUSTRIES, LP]
- HUMULIN R (INSULIN HUMAN) INJECTION, SOLUTION HUMULIN R (INSULIN HUMAN) INJECTION, SOLUTION [ELI LILLY AND COMPANY]
- HUMULIN R U-500 (INSULIN HUMAN) INJECTION, SOLUTION HUMULIN R U-500 KWIKPEN (INSULIN HUMAN) INJECTION, SOLUTION [ELI LILLY AND COMPANY]
- HUMULIN 70/30 (INSULIN HUMAN) INJECTION, SUSPENSION HUMULIN 70/30 KWIKPEN (INSULIN HUMAN) INJECTION, SUSPENSION [ELI LILLY AND COMPANY]
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.